- Deep understanding of gene therapies for ophthalmic diseases
- Extensive list of programs in rare and common ocular diseases
- Potential extension to other diseases beside blindness
Building with an innovation mindest, Neurophth is focused on new technologies (including gene therapy) and unmet medical needs, and actively committed to the global commercialization of all products.
As a fast-growing innovative biotech company, Neurophth is well positioned to:
Gene Therapy Platform
CMC Platform